Harbor Investment Advisory’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41K | Hold |
150
| – | – | ﹤0.01% | 1103 |
|
|
2025
Q1 | $1.07K | Hold |
150
| – | – | ﹤0.01% | 1112 |
|
|
2024
Q4 | $1.75K | Sell |
150
-1,650
| -92% | -$19.2K | ﹤0.01% | 1063 |
|
|
2024
Q3 | $37K | Hold |
1,800
| – | – | ﹤0.01% | 646 |
|
|
2024
Q2 | $40.3K | Hold |
1,800
| – | – | ﹤0.01% | 618 |
|
|
2024
Q1 | $49.5K | Sell |
1,800
-200
| -10% | -$5.5K | 0.01% | 585 |
|
|
2023
Q4 | $61K | Hold |
2,000
| – | – | 0.01% | 525 |
|
|
2023
Q3 | $63.2K | Sell |
2,000
-20
| -1% | -$632 | 0.01% | 497 |
|
|
2023
Q2 | $82.4K | Hold |
2,020
| – | – | 0.01% | 557 |
|
|
2023
Q1 | $75.3K | Sell |
2,020
-800
| -28% | -$29.8K | 0.01% | 582 |
|
|
2022
Q4 | $98.4K | Sell |
2,820
-400
| -12% | -$14K | 0.02% | 498 |
|
|
2022
Q3 | $180K | Buy |
3,220
+300
| +10% | +$16.8K | 0.03% | 351 |
|
|
2022
Q2 | $151K | Hold |
2,920
| – | – | 0.02% | 390 |
|
|
2022
Q1 | $212K | Sell |
2,920
-1,950
| -40% | -$142K | 0.03% | 367 |
|
|
2021
Q4 | $576K | Sell |
4,870
-1,540
| -24% | -$182K | 0.07% | 203 |
|
|
2021
Q3 | $860K | Buy |
6,410
+5,210
| +434% | +$699K | 0.12% | 151 |
|
|
2021
Q2 | $194K | Buy |
1,200
+900
| +300% | +$146K | 0.03% | 375 |
|
|
2021
Q1 | $24K | Buy |
+300
| New | +$24K | ﹤0.01% | 850 |
|
|
2020
Q1 | – | Sell |
-500
| Closed | -$7K | – | 1130 |
|
|
2019
Q4 | $7K | Buy |
+500
| New | +$7K | ﹤0.01% | 669 |
|